Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)

被引:102
|
作者
Thode, Adam R. [1 ]
Latkany, Robert A. [1 ]
机构
[1] New York Eye & Ear Infirm Mt Sinai, New York, NY 10003 USA
关键词
POLYUNSATURATED FATTY-ACIDS; DRY EYE; LIPID LAYER; DIETARY SUPPLEMENTATION; AZITHROMYCIN; EFFICACY; CLASSIFICATION; 0.05-PERCENT; MINOCYCLINE; CYTOKINES;
D O I
10.1007/s40265-015-0432-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow (R). While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N-acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
引用
收藏
页码:1177 / 1185
页数:9
相关论文
共 50 条
  • [21] MEIBOMIAN GLAND DYSFUNCTION .2. THE ROLE OF KERATINIZATION IN A RABBIT MODEL OF MGD
    JESTER, JV
    NICOLAIDES, N
    KISSPALVOLGYI, I
    SMITH, RE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1989, 30 (05) : 936 - 945
  • [22] Efficacy of Meibomian Gland Intraductal Probing for the Treatment of Meibomian Gland Dysfunction
    Bowman, Scott J.
    Bunya, Vatinee Y.
    Fernandez, Karen
    Macchi, Ilaria
    Orlin, Stephen E.
    Sulewski, Michael E.
    Ying, Gui-Shuang
    Massaro-Giordano, Mina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [23] Therapeutic Instruments Targeting Meibomian Gland Dysfunction
    Laura Valencia-Nieto
    Andrea Novo-Diez
    Marta Blanco-Vázquez
    Alberto López-Miguel
    Ophthalmology and Therapy, 2020, 9 : 797 - 807
  • [24] Therapeutic Instruments Targeting Meibomian Gland Dysfunction
    Valencia-Nieto, Laura
    Novo-Diez, Andrea
    Blanco-Vazquez, Marta
    Lopez-Miguel, Alberto
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 797 - 807
  • [25] The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
    Geerling, Gerd
    Tauber, Joseph
    Baudouin, Christophe
    Goto, Eiki
    Matsumoto, Yukihiro
    O'Brien, Terrence
    Rolando, Maurizio
    Tsubota, Kazuo
    Nichols, Kelly K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (04) : 2050 - 2064
  • [26] Meibomian gland dysfunction, dropout and distress: emerging therapies
    Hassan, Ali
    Balal, Shafi
    Ahmad, Sajjad
    EYE, 2020, 34 (09) : 1494 - 1496
  • [27] Meibomian gland dysfunction, dropout and distress: emerging therapies
    Ali Hassan
    Shafi Balal
    Sajjad Ahmad
    Eye, 2020, 34 : 1494 - 1496
  • [28] An update on emerging pharmacological treatments for meibomian gland dysfunction
    Coco, Giulia
    Giannaccare, Giuseppe
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (02) : 203 - 208
  • [29] Thermal pulsation system (LipiFlow®) for treatment of meibomian gland dysfunction (MGD) from the perspective of an ophthalmologist in private practice
    Laufenboeck, Christoph
    OPHTHALMOLOGIE, 2022, 119 (06): : 605 - 610
  • [30] Thermal pulsation system (LipiFlow®) for treatment of meibomian gland dysfunction (MGD) from the perspective of an ophthalmologist in private practice
    Laufenboeck, Christoph
    OPHTHALMOLOGE, 2021,